AstraZeneca AB v. Mylan Pharmaceuticals Inc., Appeal No. 2021-1729 (Fed. Cir. Dec. 8, 2021) -
Our Case of the Week again focuses on numerical values in claims. Last week we addressed a case involving whether there was...more
Biogen International GMBH v. Mylan Pharmaceuticals Inc., Appeal No. 2020-1933 (Fed. Cir. Nov. 30, 2021) -
For the second time in two weeks, our Case of the Week focuses on the written description requirement, in...more
University of Strathclyde v. Clear-Vu Lighting LLC, Appeal No. 2021-2243 (Fed. Cir. Nov. 4, 2021) -
In this week’s Case of the Week, the Federal Circuit reversed an inter partes review decision finding claims directed to...more
11/9/2021
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Dismissals ,
Improper Venue ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Prior Art
Belcher Pharmaceuticals, LLC v. Hospira, Inc., Appeal No. 2020-1799 (Fed. Cir. Sept. 1, 2021) -
In an appeal from the United States District Court for the District of Delaware, the Federal Circuit affirmed the district...more
9/8/2021
/ Appeals ,
Failure To Disclose ,
Food and Drug Administration (FDA) ,
Inequitable Conduct ,
Inventions ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Notice ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Trademarks ,
USPTO
MLC Intellectual Property, LLC v. Micron Technology, Inc., Appeal No. 2020-1413 (Fed. Cir. Aug. 26, 2021) -
For those interested in an important Section 112 written description case, we recommend reading the Juno...more
8/31/2021
/ Appeals ,
Apportionment ,
Damages ,
Discovery ,
Expert Testimony ,
Failure To Disclose ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Inventors ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Section 101
Teva Pharms. Int’l GmbH v. Eli Lilly and Co., Appeal Nos. 2020-1747, -1748, -1750 (Fed. Cir. Aug. 16, 2021) -
Eli Lilly and Co. v. Teva Pharms. Int’l GmbH, Appeal Nos. 2020-1876, -1877, -1878 (Fed. Cir. Aug. 16, 2021)...more
Our Case of the Week this week is a re-write of our Case of the Week on October 5, 2020. The case involves a drug that could be used for multiple therapeutic purposes. A patent covered use of the product for a specific...more
8/10/2021
/ Appeals ,
Damages ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Improper Venue ,
Inventions ,
Labeling ,
Liability ,
Motion to Dismiss ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Subject Matter Jurisdiction
Amgen Inc. v. Sanofi, Appeal No. 2020-1074 (Fed. Cir. Feb. 11, 2021) -
In this week’s Case of the Week, the Federal Circuit affirmed a district court’s JMOL ruling that asserted claims of two related pharmaceutical patents...more
2/17/2021
/ Appeals ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
JMOL ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Summary Judgment
C.R. Bard Inc. v. AngioDynamics, Inc., Appeal No. 2019-1756, -1934 (Fed. Cir. Nov. 10, 2020) -
Our Case of the Week is one of two cases decided this week in which the Federal Circuit finds that a district court jumped the...more
11/17/2020
/ Appeals ,
Appellate Courts ,
Claim Construction ,
Discovery ,
Dismissals ,
Equitable Estoppel ,
Genuine Issue of Material Fact ,
Inter Partes Review (IPR) Proceeding ,
Inventors ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Petition for Writ of Certiorari ,
Pharmaceutical Patents ,
Summary Judgment
Valeant Pharmaceuticals North America LLC v. Mylan Pharmaceuticals Inc., Appeal No. 2019-2402 (Fed. Cir. Nov. 5, 2020) -
In our Case of the Week, the Federal Circuit addressed a lingering question about venue following the...more
11/10/2020
/ Appeals ,
Claim Construction ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Investigational New Drug Application (IND) ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
SCOTUS ,
TC Heartland LLC v Kraft Foods ,
Venue
GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., Appeal No. 2018-1976, -2023 (Fed. Cir. Oct. 2, 2020) -
Our Case of the Week focuses on the question of induced infringement, and particularly induced infringement in...more
PATENT CASE OF THE WEEK -
Dana-Farber Cancer Institute, Inc. v. Ono Pharmaceutical Co., Ltd., Appeal No. 2019-2050 (Fed. Cir. July 14, 2020) -
In this week’s Case of the Week, the Federal Circuit addressed inventorship...more
PATENT CASE OF THE WEEK -
Amneal Pharmaceuticals LLC v. Almirall, LLC, Appeal No. 2020-1106 (Fed. Cir. June 4, 2020) -
In the Federal Circuit’s only precedential case this week, the Court addressed issues relating to...more
PATENT CASE OF THE WEEK -
Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC, Appeal No. 2019-1924 (Fed. Cir. May 8, 2020) -
This week’s Case of the Week features an appeal from the United States District Court for the...more
PATENT CASE OF THE WEEK -
Amgen Inc. v. Amneal Pharmaceuticals LLC, et al., Appeal Nos. 2018-2414, et al. (Fed. Cir. Jan. 7, 2020) -
In this appeal from Markman and summary judgment opinions by the district court in a...more
1/14/2020
/ Abbreviated New Drug Application (ANDA) ,
America Invents Act ,
Amgen ,
Claim Construction ,
Hatch-Waxman ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
POSITA ,
Prior Art
PATENT CASE OF THE WEEK -
Persion Pharms. LLC v. Alvogen Malta Operations Ltd., Appeal No. 2018-2361 (Fed. Cir. Dec. 27, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed a district court judgment...more
12/31/2019
/ Appeals ,
Evidence ,
Food and Drug Administration (FDA) ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Prior Art ,
Reaffirmation
PATENT CASE OF THE WEEK -
Blackbird Tech LLC v. Health in Motion LLC, Appeal No. 2018-2393 (Fed. Cir. Dec. 16, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed a fee award against prevailing...more
12/24/2019
/ Amgen v Hospira ,
Appeals ,
Claim Construction ,
Frivolous Lawsuits ,
Judgment As A Matter Of Law ,
Jury Verdicts ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Safe Harbors ,
Statutory Interpretation ,
Subject Matter Jurisdiction ,
Vacated
PATENT CASE OF THE WEEK -
HZNP Medicines LLC v. Actavis Laboratories UT, Inc., Appeal Nos. 2017-2149, et al. (Fed. Cir. Oct. 10, 2019) -
In a lengthy decision following a bench trial, the Court addressed a matter of...more
10/22/2019
/ Abbreviated New Drug Application (ANDA) ,
Failure To State A Claim ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
Nautilus Inc. v. Biosig Instruments ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
POSITA ,
Prevailing Party ,
Remand ,
Reversal
PATENT CASE OF THE WEEK -
HZNP Medicines LLC v. Actavis Laboratories UT, Inc., Appeal Nos. 2017-2149, et al. (Fed. Cir. Oct. 10, 2019) -
In a lengthy decision following a bench trial, the Court addressed a matter of...more
10/15/2019
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Attorney's Fees ,
Facebook ,
Hatch-Waxman ,
Indefiniteness ,
Induced Infringement ,
Inter Partes Review (IPR) Proceeding ,
Judgment on the Pleadings ,
Litigation Fees & Costs ,
Mootness ,
Motion to Dismiss ,
Nonobvious ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Prevailing Party ,
Reaffirmation
PATENT CASE OF THE WEEK -
BioDelivery Sciences Int’l, Inc. v. Aquestive Therapeutics, Inc., Appeal Nos. 2019-1643, -1644, -1645 (Fed. Cir. Aug. 29, 2019) -
Our case of the week this week focuses on Section 314(d)—the...more
9/4/2019
/ America Invents Act ,
Anticipation ,
Appeals ,
Indefiniteness ,
Intellectual Property Litigation ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Investigational New Drug Application (IND) ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Remand ,
Vacated
PATENT CASE OF THE WEEK -
Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories, FL, Inc., Appeal No. 2018-1221 (Fed. Cir. Aug. 15, 2019) -
This week’s Case of the Week focuses on issues relating to written...more
8/20/2019
/ Abbreviated New Drug Application (ANDA) ,
Claim Construction ,
Claim Limitations ,
Hatch-Waxman ,
Motion to Amend ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Section 101 ,
Written Descriptions
PATENT CASE OF THE WEEK -
Celgene Corporation v. Laura A. Peter, Appeal Nos. 2018-1167, -1168, -1169, -1171 (Fed. Cir. July 30, 2019) -
In this week’s Case of the Week, the Federal Circuit held that the retroactive...more
8/6/2019
/ Dismissals ,
Doctrine of Equivalents ,
Estoppel ,
Failure To State A Claim ,
Fifth Amendment ,
Inter Partes Reexamination ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Reversal ,
Section 101 ,
USPTO
PATENT CASE OF THE WEEK -
General Electric Co. v. United Techs. Corp., Appeal No. 2017-2497 (Fed. Cir. July 10, 2019) -
The Case of the Week focuses on standing to bring an appeal of an adverse decision by the PTAB in...more
7/16/2019
/ Administrative Procedure Act ,
Appeals ,
Article III ,
Claim Construction ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Standing ,
Vacated
PATENT CASE OF THE WEEK -
Elbit Systems Land and C4I Ltd. v. Hughes Network Systems, LLC, Appeal No. 2018-1910 (Fed. Cir. June 25, 2019) -
In this appeal from the United States District Court for the Eastern District of...more
7/2/2019
/ Appeals ,
Attorney's Fees ,
Damages ,
Dismissals ,
Doctrine of Equivalents ,
Exceptional Case ,
Expert Testimony ,
Lack of Jurisdiction ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Section 101 ,
Substantial Evidence ,
Vacated
PATENT CASE OF THE WEEK -
AVX Corporation v. Presidio Components, Inc., Appeal No. 2018-1106 (Fed. Cir. May 13, 2019) -
Following an inter partes review upholding the patentability of certain challenged claims, the...more
5/22/2019
/ Abbreviated New Drug Application (ANDA) ,
Article III ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Standing ,
USPTO